68Ga-PSMA and 11C-Choline comparison using a tri-modality PET/CT-MRI (3.0 T) system with a dedicated shuttle

Abstract Background The aim of this study was to prospectively compare the detection rate of 68Ga-PSMA versus 11C-Choline in men with prostate cancer with biochemical recurrence and to demonstrate the added value of a tri-modality PET/CT-MRI system. Methods We analysed 36 patients who underwent both...

Full description

Bibliographic Details
Main Authors: Omar Alonso, Gerardo dos Santos, Margarita García Fontes, Henia Balter, Henry Engler
Format: Article
Language:English
Published: SpringerOpen 2018-05-01
Series:European Journal of Hybrid Imaging
Subjects:
Online Access:http://link.springer.com/article/10.1186/s41824-018-0027-1
id doaj-b1a487aca3df432ca46f38b41a168c80
record_format Article
spelling doaj-b1a487aca3df432ca46f38b41a168c802020-11-25T01:30:13ZengSpringerOpenEuropean Journal of Hybrid Imaging2510-36362018-05-012111610.1186/s41824-018-0027-168Ga-PSMA and 11C-Choline comparison using a tri-modality PET/CT-MRI (3.0 T) system with a dedicated shuttleOmar Alonso0Gerardo dos Santos1Margarita García Fontes2Henia Balter3Henry Engler4Uruguayan Centre of Molecular Imaging (CUDIM)Uruguayan Centre of Molecular Imaging (CUDIM)Uruguayan Centre of Molecular Imaging (CUDIM)Uruguayan Centre of Molecular Imaging (CUDIM)Uruguayan Centre of Molecular Imaging (CUDIM)Abstract Background The aim of this study was to prospectively compare the detection rate of 68Ga-PSMA versus 11C-Choline in men with prostate cancer with biochemical recurrence and to demonstrate the added value of a tri-modality PET/CT-MRI system. Methods We analysed 36 patients who underwent both 11C-Choline PET/CT and 68Ga-PSMA PET/CT scanning within a time window of 1-2 weeks. Additionally, for the 68Ga-PSMA scan, we used a PET/CT-MRI (3.0 T) system with a dedicated shuttle, acquiring MRI images of the pelvis. Results Both scans were positive in 18 patients (50%) and negative in 8 patients (22%). Nine patients were positive with 68Ga-PSMA alone (25%) and one with 11C-Choline only (3%). The median detected lesion per patient was 2 for 68Ga-PSMA (range 0-93) and 1 for 11C-Choline (range 0-57). Tumour to background ratios in all concordant lesions (n = 96) were higher for 68Ga-PSMA than for 11C-Choline (110.3 ± 107.8 and 27.5 ± 17.1, mean ± S.D., for each tracer, respectively P = 0.0001). The number of detected lesions per patient was higher for 11C-Choline in those with PSA ≥ 3.3 ng/mL, while the number of detected lesions was independent of PSA levels for 68Ga-PSMA using the same PSA cut-off value. Metastatic pelvic lesions were found in 25 patients (69%) with 68Ga-PSMA PET/CT, in 18 (50%) with 11C-Choline PET/CT and in 21 (58%) with MRI (3.0 T). MRI was very useful in detecting recurrence in cases classified as indeterminate by means of PET/CT alone at prostate bed. Conclusions In patients with prostate cancer with biochemical recurrence 68Ga-PSMA detected more lesions per patient than 11C-Choline, regardless of PSA levels. PET/CT-MRI (3.0 T) system is a feasible imaging modality that potentially adds useful relevant information with increased accuracy of diagnosis.http://link.springer.com/article/10.1186/s41824-018-0027-1Prostate cancerBiochemical recurrence11C-Choline68Ga-PSMAPET/CTPET/MRI
collection DOAJ
language English
format Article
sources DOAJ
author Omar Alonso
Gerardo dos Santos
Margarita García Fontes
Henia Balter
Henry Engler
spellingShingle Omar Alonso
Gerardo dos Santos
Margarita García Fontes
Henia Balter
Henry Engler
68Ga-PSMA and 11C-Choline comparison using a tri-modality PET/CT-MRI (3.0 T) system with a dedicated shuttle
European Journal of Hybrid Imaging
Prostate cancer
Biochemical recurrence
11C-Choline
68Ga-PSMA
PET/CT
PET/MRI
author_facet Omar Alonso
Gerardo dos Santos
Margarita García Fontes
Henia Balter
Henry Engler
author_sort Omar Alonso
title 68Ga-PSMA and 11C-Choline comparison using a tri-modality PET/CT-MRI (3.0 T) system with a dedicated shuttle
title_short 68Ga-PSMA and 11C-Choline comparison using a tri-modality PET/CT-MRI (3.0 T) system with a dedicated shuttle
title_full 68Ga-PSMA and 11C-Choline comparison using a tri-modality PET/CT-MRI (3.0 T) system with a dedicated shuttle
title_fullStr 68Ga-PSMA and 11C-Choline comparison using a tri-modality PET/CT-MRI (3.0 T) system with a dedicated shuttle
title_full_unstemmed 68Ga-PSMA and 11C-Choline comparison using a tri-modality PET/CT-MRI (3.0 T) system with a dedicated shuttle
title_sort 68ga-psma and 11c-choline comparison using a tri-modality pet/ct-mri (3.0 t) system with a dedicated shuttle
publisher SpringerOpen
series European Journal of Hybrid Imaging
issn 2510-3636
publishDate 2018-05-01
description Abstract Background The aim of this study was to prospectively compare the detection rate of 68Ga-PSMA versus 11C-Choline in men with prostate cancer with biochemical recurrence and to demonstrate the added value of a tri-modality PET/CT-MRI system. Methods We analysed 36 patients who underwent both 11C-Choline PET/CT and 68Ga-PSMA PET/CT scanning within a time window of 1-2 weeks. Additionally, for the 68Ga-PSMA scan, we used a PET/CT-MRI (3.0 T) system with a dedicated shuttle, acquiring MRI images of the pelvis. Results Both scans were positive in 18 patients (50%) and negative in 8 patients (22%). Nine patients were positive with 68Ga-PSMA alone (25%) and one with 11C-Choline only (3%). The median detected lesion per patient was 2 for 68Ga-PSMA (range 0-93) and 1 for 11C-Choline (range 0-57). Tumour to background ratios in all concordant lesions (n = 96) were higher for 68Ga-PSMA than for 11C-Choline (110.3 ± 107.8 and 27.5 ± 17.1, mean ± S.D., for each tracer, respectively P = 0.0001). The number of detected lesions per patient was higher for 11C-Choline in those with PSA ≥ 3.3 ng/mL, while the number of detected lesions was independent of PSA levels for 68Ga-PSMA using the same PSA cut-off value. Metastatic pelvic lesions were found in 25 patients (69%) with 68Ga-PSMA PET/CT, in 18 (50%) with 11C-Choline PET/CT and in 21 (58%) with MRI (3.0 T). MRI was very useful in detecting recurrence in cases classified as indeterminate by means of PET/CT alone at prostate bed. Conclusions In patients with prostate cancer with biochemical recurrence 68Ga-PSMA detected more lesions per patient than 11C-Choline, regardless of PSA levels. PET/CT-MRI (3.0 T) system is a feasible imaging modality that potentially adds useful relevant information with increased accuracy of diagnosis.
topic Prostate cancer
Biochemical recurrence
11C-Choline
68Ga-PSMA
PET/CT
PET/MRI
url http://link.springer.com/article/10.1186/s41824-018-0027-1
work_keys_str_mv AT omaralonso 68gapsmaand11ccholinecomparisonusingatrimodalitypetctmri30tsystemwithadedicatedshuttle
AT gerardodossantos 68gapsmaand11ccholinecomparisonusingatrimodalitypetctmri30tsystemwithadedicatedshuttle
AT margaritagarciafontes 68gapsmaand11ccholinecomparisonusingatrimodalitypetctmri30tsystemwithadedicatedshuttle
AT heniabalter 68gapsmaand11ccholinecomparisonusingatrimodalitypetctmri30tsystemwithadedicatedshuttle
AT henryengler 68gapsmaand11ccholinecomparisonusingatrimodalitypetctmri30tsystemwithadedicatedshuttle
_version_ 1725092804267343872